Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.38 | N/A | +15.85% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.38 | N/A | +15.85% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on their product lines. They emphasized the importance of strategic initiatives moving forward.
Management highlighted strong performance in key product categories.
They expressed confidence in maintaining momentum despite market challenges.
The earnings report indicates that Prestige Consumer HE exceeded expectations on EPS, which likely contributed to the significant stock increase of 18.46%. The positive surprise in earnings suggests that the company is managing its costs effectively and performing well in its market segments. However, the lack of revenue data and guidance leaves some uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
PG&E CORP
Oct 29, 2012